✦ LIBER ✦

Long-term follow-up of multivessel percutaneous coronary intervention with drug-eluting stents for de novo lesions with correlation to the SYNTAX score

✍ Scribed by Robert T. Gerber; Alfonso Ielasi; Rasha Al-Lamee; Azeem Latib; Flavio Airoldi; Massimo Ferraro; Luca Ferri; Giorgio Bassanelli; Cosmo Godino; Andrew S.P. Sharp; Alaide Chieffo; Mauro Carlino; Matteo Montorfano; Giuseppe M. Sangiorgi; Antonio Colombo

Book ID: 113516151
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 240 KB
Volume: 12
Category: Article
ISSN: 1553-8389
DOI: 10.1016/j.carrev.2010.10.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of percutaneous cathet

Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents

✍ Miroslaw Ferenc; Michael Gick; Rolf-Peter Kienzle; Hans-Peter Bestehorn; Klaus-D 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 612 KB

172 Paucity of Events in the Long Term F

172 Paucity of Events in the Long Term Follow Up Of Patients With Coronary Bifurcation Lesions Treated With Drug Eluting Stents

✍ L. Ngunga; P. Cheung; S. Bundhoo; N. Brass; B. Tyrrell; R. Leung; A.A. Harbi; M. 📂 Article 📅 2012 🏛 Pulsus Group Inc 🌐 English ⚖ 218 KB

Five-year long-term clinical follow-up o

Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial

✍ Marcus Wiemer; Patrick W. Serruys; Karine Miquel-Hebert; Franz-Josef Neumann; Ja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

AS-163 The Impact of Bifurcation Lesions

AS-163 The Impact of Bifurcation Lesions on 6-month Angiographic and Long term Clinical Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

✍ Jae Woong Choi; Ji Young Park; Seung-Woon Rha; Sung Kee Ryu; Amro Elnagar; Byoun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB